ARVEE

Arvee Laboratories (India) Share Price

 

 

Start SIP in ARVEE

Start SIP

Performance

  • Low
  • ₹161
  • High
  • ₹163
  • 52 Week Low
  • ₹127
  • 52 Week High
  • ₹233
  • Open Price₹163
  • Previous Close₹162
  • Volume532

Investment Returns

  • Over 1 Month -0.23%
  • Over 3 Month -5.78%
  • Over 6 Month + 7.26%
  • Over 1 Year -5.56%

Smart Investing Starts Here Start SIP with Arvee Laboratories (India) for Steady Growth!

Invest Now

Arvee Laboratories (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 129.2
  • PEG Ratio
  • -14.7
  • Market Cap Cr
  • 178
  • P/B Ratio
  • 5.7
  • Average True Range
  • 6.9
  • EPS
  • 1.25
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.81
  • RSI
  • 48.39
  • MFI
  • 43.69

Arvee Laboratories (India) Financials

Arvee Laboratories (India) Technicals

EMA & SMA

Current Price
₹161.10
-1.35 (-0.83%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹161.75
  • 50 Day
  • ₹163.45
  • 100 Day
  • ₹164.60
  • 200 Day
  • ₹164.85

Resistance and Support

161.82 Pivot Speed
  • R3 164.70
  • R2 163.98
  • R1 162.54
  • S1 160.38
  • S2 159.66
  • S3 158.22

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Arvee Laboratories (India) has an operating revenue of Rs. 35.37 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 7% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around -0% and 1% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 24% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at D+ which indicates heavy supply, Group Rank of 118 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Arvee Laboratories (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-08-12 Quarterly Results
2025-05-09 Audited Results & Others To consider Other business matters.
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results & Others To consider other business matters.
2024-08-13 Quarterly Results

Arvee Laboratories (India) F&O

Arvee Laboratories (India) Shareholding Pattern

73.5%
26.19%
0.31%

About Arvee Laboratories (India)

  • NSE Symbol
  • ARVEE
  • BSE Symbol
  • Managing Director
  • Mr. Shalin Sudhakarbhai Patel
  • ISIN
  • INE006Z01016

Similar Stocks to Arvee Laboratories (India)

Arvee Laboratories (India) FAQs

Arvee Laboratories (India) share price is ₹161 As on 11 November, 2025 | 21:53

The Market Cap of Arvee Laboratories (India) is ₹177.5 Cr As on 11 November, 2025 | 21:53

The P/E ratio of Arvee Laboratories (India) is 129.2 As on 11 November, 2025 | 21:53

The PB ratio of Arvee Laboratories (India) is 5.7 As on 11 November, 2025 | 21:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23